AR046851A1 - Procesos para la preparacion de pirazolo(1,5-alfa)-1,3,5-triazinas e intermedios de las mismas - Google Patents

Procesos para la preparacion de pirazolo(1,5-alfa)-1,3,5-triazinas e intermedios de las mismas

Info

Publication number
AR046851A1
AR046851A1 ARP040104336A ARP040104336A AR046851A1 AR 046851 A1 AR046851 A1 AR 046851A1 AR P040104336 A ARP040104336 A AR P040104336A AR P040104336 A ARP040104336 A AR P040104336A AR 046851 A1 AR046851 A1 AR 046851A1
Authority
AR
Argentina
Prior art keywords
compound
formula
alkyl
independently
intermediates
Prior art date
Application number
ARP040104336A
Other languages
English (en)
Inventor
Jaan A Pesti
Robert E Yule
James P Sherbine
Shawn K Pack
Kenneth C Mcnulty
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of AR046851A1 publication Critical patent/AR046851A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

El presente proporciona procesos e intermedios para preparar antagonistas del receptor de liberación de corticotropina (CRF), que son útiles en el tratamiento de trastornos relacionados con CRF tales como ansiedad y depresión. Reivindicación 1: Un proceso para preparar un compuesto de fórmula (1), en la que: Ar es fenilo o piridilo sustituido con de 0 a 5 R3; cada uno de R1 y R2 es, independientemente, H, alquilo (C1-8), o alcoxialquilo (C1-6); cada R3 es, independientemente, H, halo, CN, nitro, alquilo (C1-4), alcoxi (C1-4), haloalquilo (C1-4), o haloalcoxi (C1-4); y cada uno de RA y RB es, independientemente, alquilo (C1-4), que comprende: a) poner en contacto un compuesto de fórmula (2), con POX3 en presencia de una amina seleccionada entre diisopropiletilamina, dietilfenilamina, diisopropilanilina, dietilanilina, disopropilisobutilamina, tribencilamina, trifenilamina, triciclohexilamina, o dietilisopropilamina, donde X es halo, durante un tiempo y en unas condiciones de reacción suficientes para proporcionar un compuesto de fórmula (3), y b) poner en contacto el compuesto de fórmula (3) con NHR1R2 durante un tiempo y en unas condiciones suficientes para proporcionar un compuesto de fórmula (1).
ARP040104336A 2003-11-25 2004-11-24 Procesos para la preparacion de pirazolo(1,5-alfa)-1,3,5-triazinas e intermedios de las mismas AR046851A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52505003P 2003-11-25 2003-11-25
US10/985,236 US7208596B2 (en) 2003-11-25 2004-11-10 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof

Publications (1)

Publication Number Publication Date
AR046851A1 true AR046851A1 (es) 2005-12-28

Family

ID=34636532

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104336A AR046851A1 (es) 2003-11-25 2004-11-24 Procesos para la preparacion de pirazolo(1,5-alfa)-1,3,5-triazinas e intermedios de las mismas

Country Status (15)

Country Link
US (2) US7208596B2 (es)
EP (1) EP1706408A2 (es)
JP (1) JP2007512360A (es)
KR (1) KR20060116208A (es)
AR (1) AR046851A1 (es)
AU (1) AU2004293435A1 (es)
BR (1) BRPI0416821A (es)
CA (1) CA2546652A1 (es)
IL (1) IL175753A0 (es)
MX (1) MXPA06005482A (es)
NO (1) NO20062943L (es)
PE (1) PE20051045A1 (es)
RU (1) RU2006121075A (es)
TW (1) TW200529827A (es)
WO (1) WO2005051954A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2011093352A1 (ja) 2010-01-27 2011-08-04 武田薬品工業株式会社 チアゾール誘導体
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
AR086554A1 (es) 2011-05-27 2014-01-08 Novartis Ag Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina
AU2013255458A1 (en) 2012-05-03 2014-10-09 Novartis Ag L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910907A (en) 1973-07-09 1975-10-07 Icn Pharmaceuticals Pyrazolo(1,5-a)-1,3,5-triazines
US4824834A (en) 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
DE3722072A1 (de) 1987-07-01 1989-01-12 Schering Ag 6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung
JP2691317B2 (ja) 1989-08-25 1997-12-17 株式会社大塚製薬工場 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法
US5484760A (en) 1990-12-31 1996-01-16 Monsanto Company Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
AU667575B2 (en) 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
CN1088574A (zh) 1992-12-24 1994-06-29 中国科学院化学研究所 2,6-二甲基-4-叔丁基-3-硝基-苯乙氰的合成方法
US6124289A (en) 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
AU747708B2 (en) 1996-07-24 2002-05-23 Du Pont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
EP0923582B1 (en) 1996-08-28 2006-09-20 Pfizer Inc. Substituted 6,5-hetero-bicyclic derivatives
ES2204798T3 (es) * 1998-12-21 2004-05-01 Lonza Ag Procedimiento para la preparacion de 2,5-diamino-4,6-dihalogenopirimidina.
OA12049A (en) 1999-09-30 2006-05-02 Neurogen Corp Amino substituted pyrazoloÄ1,5,-aÜ-1,5-pyrimidinesand pyrazoloÄ1,5,-aÜ-1,3,5-triazines.
JP2001302658A (ja) 2000-04-18 2001-10-31 Showa Denko Kk ３−イソクロマノン類の製造方法
WO2002072202A1 (en) * 2001-03-13 2002-09-19 Bristol-Myers Squibb Pharma Company 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof

Also Published As

Publication number Publication date
US20070161790A1 (en) 2007-07-12
WO2005051954A2 (en) 2005-06-09
NO20062943L (no) 2006-08-25
TW200529827A (en) 2005-09-16
BRPI0416821A (pt) 2007-03-06
CA2546652A1 (en) 2005-06-09
WO2005051954A3 (en) 2005-11-17
EP1706408A2 (en) 2006-10-04
RU2006121075A (ru) 2008-01-10
US7442792B2 (en) 2008-10-28
MXPA06005482A (es) 2006-08-11
JP2007512360A (ja) 2007-05-17
US20050143380A1 (en) 2005-06-30
AU2004293435A1 (en) 2005-06-09
US7208596B2 (en) 2007-04-24
IL175753A0 (en) 2006-09-05
PE20051045A1 (es) 2005-12-29
KR20060116208A (ko) 2006-11-14

Similar Documents

Publication Publication Date Title
PE20141191A1 (es) Compuestos como inhibidores de bace
PE20210461A1 (es) Compuestos de azol-amida pesticidamente activos
PE20141041A1 (es) Compuestos, metodos y formulaciones parasiticidas
CO5611151A2 (es) Derivados de acido 4-(piperidin-1-il) piperidina-1-acetico como moduladores le 11 5rh
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
PE20070041A1 (es) Amidas de acido pirazolcarboxilico
AR054130A1 (es) Procedimiento para la preparacion de 1-alquil-3-feniluracilos
AR033295A1 (es) Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica
CY1111185T1 (el) Ανθρανιλαμιδια, μεθοδος για την παρασκευη αυτων και παραγοντες ελεγχου επιβλαβων εντομων που τα περιεχουν
PE20130188A1 (es) Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk
AR059516A1 (es) Derivados de isoxazolina, procesos de obtencion y composiciones herbicidas
AR038717A1 (es) Ciclopropil-azol-carboxamidas
CR20140045A (es) Compuestos de n-tio-antranilamida y sus usos como plaguicidas
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
AR060489A1 (es) Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol
PE20121047A1 (es) Derivados de tiazolilpiperidina como fungicidas
AR067413A1 (es) Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer
AR056979A1 (es) Derivados de dihidrobenzofuranos y usos de los mismos
AR046851A1 (es) Procesos para la preparacion de pirazolo(1,5-alfa)-1,3,5-triazinas e intermedios de las mismas
PE20142282A1 (es) Nuevos derivados de aril-quinolina
NZ581438A (en) Kallikrein 7 modulators
DK1751117T3 (da) Fremgangsmåde til fremstilling af aminopyrimidiner
AR074735A1 (es) Herbicidas derivados de ciclopentanodiona
CO4761023A1 (es) Compuestos de pirazol, procesos para su produccion y herbi- cidas que los contienen
EA200971063A1 (ru) Ариламидпиримидоновые соединения

Legal Events

Date Code Title Description
FB Suspension of granting procedure